Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia

Θεόδωρος Αγοραστός, Violetta Vaitsi, Minas Paschopoulos, Andromache Vakiani, Vassiliki Zournatzi-Koiou, H. Saravelos, Evanthia Kostopoulou, Theodoros C. Constantinidis, Konstantinos Dinas, Dimitrios Vavilis, Dimitrios Lolis, J. Bontis
In: Maturitas · 2003 · vol. 48(2) , pp. 125–132 · doi:10.1016/j.maturitas.2003.08.008 · PMID:15172086 · W2109640284
article OA: closed CC0 ⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the efficacy and safety of using a GnRH agonist with tibolone as add-back therapy for treating endometrial hyperplasia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

Cited by (9)

Source provenance

openalex
last seen: 2026-05-14T06:09:40.812857+00:00
License: CC0 · commercial use OK